Diabetes Research Institute Foundation Appoints Matthew Stubbs as Secretary of the Executive Board for the National Board of Directors

Matthew Stubbs

MIAMI (August XX, 2022) – The Diabetes Research Institute Foundation (DRIF) recently appointed Matthew Stubbs, managing partner at Duncan Stubbs, PLLC, to secretary of the executive board for the national board of directors. Stubbs joined the board in January 2022, bringing with him a wide range of leadership, executive and personal experiences in the diabetes community.

A seasoned legal professional with more than a decade of experience, Matthew currently serves as the managing partner at Duncan Stubbs, PLLC. In his role, he provides counsel for individuals harmed by pharmaceutical drugs, medical devices, and consumer products. Matthew has lived with type 1 diabetes since he was 12 years old, and his experience with the disease has motivated him to support finding a cure for diabetes so that others facing diabetes can experience full health.

“I am honored to be appointed to the executive board for the national board of directors of an organization whose mission is so meaningful and personal to me,” said Matthew Stubbs, managing attorney partner at Duncan Stubbs, PLLC. “This appointment represents the opportunity to make a lasting impact on the lives of those impacted by diabetes. I am looking forward to using my experience and connections to bring the DRI closer to finding a cure for diabetes.”

Matthew will serve in his board role until June 30, 2023. For more information about DRIF, its mission and its board of directors, visit:

# # # 

About the Diabetes Research Institute (DRI) and Foundation  

The Diabetes Research Institute (DRI) and Foundation were created for one reason – to cure diabetes – which is and will continue to be the singular focus until that goal is reached. As one of the largest and most comprehensive research centers dedicated to curing diabetes, the DRI is working to restore natural insulin production and normalize blood sugar levels without imposing other risks. Researchers have already shown that transplanted insulin-producing islet cells allow people with type 1 diabetes to live without the need for insulin injections. Some of the DRI’s islet transplant patients have been free from insulin for more than 10 years. Funding provided by the Foundation is the driving force that allows DRI scientists to pursue new and innovative ideas, and to speed these discoveries to patients. The Diabetes Research Institute Foundation is the organization of choice for those who want to Be Part of the Cure. For more information, please visit or call 800-321-3437. 


Keep Up With Our Progress Toward A Cure & More